|Articles|September 1, 2018
- Applied Clinical Trials-09-01-2018
- Volume 27
- Issue 9
Applied Clinical Trials, September 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials September 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Greater Gift's PopUp Star Eventalmost 8 years ago
Can FDA Put Some Heat Back Under European Adaptive Pathways?almost 8 years ago
Next-Generation Clinical Trialsalmost 8 years ago
Clinical Trials In a Dish: A Revolution Beginsalmost 8 years ago
EU’s Status on IDMPalmost 8 years ago
Ensuring High-Quality Data in Complex, In-Home Clinical Trialsalmost 8 years ago
FDA Promotes Surrogate Endpoints, ‘Seamless’ Clinical Trialsalmost 8 years ago
Genetic Testing in Clinical Trials: A New Level of Patient Centricityalmost 8 years ago
Q&A: Clinical Trials Need To Grow In Relevancealmost 8 years ago
Designing and Executing a Gene Testing Counseling and Disclosure ProcessAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
You've Been Spending Recruitment Money at the Wrong End of the Funnel
2
ACT Brief: NIH Funding Reshaping Development Strategy, Business Decision Setting Execution Course, and Complex Modality Platform Gaps
3
ACT Brief: Trial Execution Cost Burden and Protocol Variability, Real-World Oncology Data Curation Complexity, and Real-Time Analytics Datapoint Scale
4
$500,000 Lost a Day: The Economics of Clinical Trial Execution Is Pharma's Expensive Secret
5